Genmab
GMAB
$28.33
Share price
-0.70%
Change (1 day)
-32.01%
Change (1 year)
Categories
P/S ratio for Genmab (GMAB)
P/S ratio as of April 2024 (TTM): 7.70
According to Genmab's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.70457. At the end of 2023 the company had a P/S ratio of 8.68.
P/S ratio history for Genmab from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 8.68 | -36.18% |
| 2022 | 13.6 | -31.22% |
| 2021 | 19.8 | 15.94% |
| 2020 | 17.1 | -4.97% |
| 2019 | 18.0 | -14.98% |
| 2018 | 21.1 | -22.41% |
| 2017 | 27.2 | -28.12% |
| 2016 | 37.9 | -20.62% |
| 2015 | 47.7 | 111.05% |
| 2014 | 22.6 | 32.01% |
| 2013 | 17.1 | 109.06% |
| 2012 | 8.19 | 80.95% |
| 2011 | 4.53 | -23.31% |
| 2010 | 5.90 |